Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CMPX | US
-0.01
-0.54%
Healthcare
Biotechnology
30/06/2024
21/10/2024
1.85
1.90
1.94
1.84
Compass Therapeutics Inc. a clinical-stage oncology-focused biopharmaceutical company engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates include CTX-009 a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1 and vascular endothelial growth factor A signaling pathways which are critical to angiogenesis and tumor vascularization; and CTX-471 an IgG4 monoclonal antibody that is an agonist of CD137 a key co-stimulatory receptor on immune cells. It also develops CTX-8371 a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics Inc. was founded in 2014 and is headquartered in Boston Massachusetts.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
109.0%1 month
88.6%3 months
93.1%6 months
87.0%-
-
1.79
-
-
-8.92
137.61
-
-54.50M
254.54M
254.54M
-
-1.77K
-
-
-30.05
5.14
2.56
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.48
Range1M
0.50
Range3M
1.21
Rel. volume
0.52
Price X volume
489.03K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| THL Credit Inc. 6.75% Notes du | TCRX | Biotechnology | 5.27 | 279.17M | -1.86% | n/a | 35.68% |
| Vanda Pharmaceuticals Inc | VNDA | Biotechnology | 4.73 | 275.71M | -3.67% | n/a | 1.55% |
| Progenitor Inc | PGEN | Biotechnology | 0.9272 | 271.34M | -2.72% | n/a | 14.69% |
| Ocugen Inc | OCGN | Biotechnology | 0.9384 | 270.13M | -0.17% | n/a | 40.56% |
| Enanta Pharmaceuticals Inc | ENTA | Biotechnology | 12.64 | 267.82M | 0.08% | n/a | 151.88% |
| ChromaDex Corporation | CDXC | Biotechnology | 3.46 | 262.73M | -1.14% | n/a | 10.17% |
| Rigel Pharmaceuticals Inc | RIGL | Biotechnology | 14.81 | 260.58M | -1.99% | n/a | -201.68% |
| Mersana Therapeutics Inc | MRSN | Biotechnology | 2.1 | 257.62M | 0.00% | n/a | 383.37% |
| 2seventy bio Inc | TSVT | Biotechnology | 4.97 | 255.94M | -0.40% | n/a | 107.07% |
| Nektar Therapeutics | NKTR | Biotechnology | 1.39 | 255.87M | -1.42% | n/a | 275.58% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CPI Card Group Inc | PMTS | Building Products & Equipment | 23.4 | 261.09M | -1.39% | 15.61 | -621.78% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.53 | 236.68M | -1.96% | 9.09 | 39.79% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.55 | 145.88M | -0.79% | n/a | 58.43% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.87 | 94.40M | 1.83% | 5.16 | 19.82% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 14.22 | 89.04M | -1.80% | 14.48 | 7.10% |
| Urban One Inc | UONEK | Broadcasting - Radio | 1.01 | 53.54M | -3.35% | n/a | 268.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
| ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.92 | - | Cheaper |
| Ent. to Revenue | 137.61 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.79 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 93.10 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 254.54M | - | Emerging |